138 related articles for article (PubMed ID: 27428340)
1. [Current status of alternative therapies renal function at the Instituto Mexicano del Seguro Social].
Méndez-Durán A; Ignorosa-Luna MH; Pérez-Aguilar G; Rivera-Rodríguez FJ; González-Izquierdo JJ; Dávila-Torres J
Rev Med Inst Mex Seguro Soc; 2016; 54(5):588-93. PubMed ID: 27428340
[TBL] [Abstract][Full Text] [Related]
2. [The Instituto Mexicano del Seguro Social gives dialysis therapies to 426 students without cost].
Méndez-Durán A; Ignorosa-Luna MH; Pérez-Aguilar G; Rivera-Rodríguez FJ; López-Ocaña LR
Rev Med Inst Mex Seguro Soc; 2018; 56(2):163-166. PubMed ID: 29902370
[TBL] [Abstract][Full Text] [Related]
3. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
[TBL] [Abstract][Full Text] [Related]
4. [Economic impact of the chronic kidney disease: Perspective of the Instituto Mexicano del Seguro Social].
Cortés-Sanabria L; Álvarez-Santana G; Orozco-González CN; Soto-Molina H; Martínez-Ramírez HR; Cueto-Manzano AM
Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S124-32. PubMed ID: 29697222
[TBL] [Abstract][Full Text] [Related]
5. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
6. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
7. Dialysis patients refusing kidney transplantation: data from the Slovenian Renal Replacement Therapy Registry.
Buturović-Ponikvar J; Gubenšek J; Arnol M; Bren A; Kandus A; Ponikvar R
Ther Apher Dial; 2011 Jun; 15(3):245-9. PubMed ID: 21624070
[TBL] [Abstract][Full Text] [Related]
8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
9. [Costs and sick leave due to chikungunya in the Instituto Mexicano del Seguro Social in Guerrero, Mexico].
Vázquez-Cruz I; Juanico-Morales G; Sánchez-Ramos A; Morales-Sánchez OJ
Rev Med Inst Mex Seguro Soc; 2018; 56(1):54-63. PubMed ID: 29368896
[TBL] [Abstract][Full Text] [Related]
10. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
[TBL] [Abstract][Full Text] [Related]
12. [Malignant tumors as cause of disability at the Instituto Mexicano del Seguro Social].
Zitle-García EJ; Sauceda-Valenzuela AL; Ascencio-Montiel IJ; García-Paredes J
Rev Med Inst Mex Seguro Soc; 2018; 56(2):173-179. PubMed ID: 29906025
[TBL] [Abstract][Full Text] [Related]
13. End stage renal disease in Brunei Darussalam - report from the first Brunei Dialysis Transplant Registry (BDTR).
Tan J
Ren Fail; 2013 Sep; 35(8):1101-4. PubMed ID: 23879396
[TBL] [Abstract][Full Text] [Related]
14. Slovenian Renal Replacement Therapy Registry: excerpts from the 2008 Annual Report.
Buturović-Ponikvar J; Gubenšek J; Arnol M
Ther Apher Dial; 2011 Jun; 15(3):228-33. PubMed ID: 21624067
[TBL] [Abstract][Full Text] [Related]
15. Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices.
Hanko J; Romann A; Taylor P; Copland M; Beaulieu M
Nephrol Dial Transplant; 2012 Nov; 27(11):4205-10. PubMed ID: 22962410
[TBL] [Abstract][Full Text] [Related]
16. [Influence of Instituto Mexicano de Seguro Social in the general mortality (1990-2005)].
Fernández-Cantón S
Rev Med Inst Mex Seguro Soc; 2010; 48(3):339-47. PubMed ID: 21192912
[TBL] [Abstract][Full Text] [Related]
17. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
[TBL] [Abstract][Full Text] [Related]
18. The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.
Lassalle M; Ayav C; Frimat L; Jacquelinet C; Couchoud C;
Nephrol Ther; 2015 Apr; 11(2):78-87. PubMed ID: 25457107
[TBL] [Abstract][Full Text] [Related]
19. [Seventy years of medicine in the Instituto Mexicano del Seguro Social].
Fajardo-Ortiz G
Rev Med Inst Mex Seguro Soc; 2014; 52(2):228-31. PubMed ID: 24758865
[TBL] [Abstract][Full Text] [Related]
20. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
Goovaerts T; Jadoul M; Goffin E
Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
